IMPAX Receives FDA Approval for Generic Versions of Urecholine(R) Tablets (Business Wire via Yahoo! Finance)
HAYWARD, Calif.----IMPAX Laboratories, Inc. today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Applications for generic versions of Urecholine Tablets 5 mg, 10 mg, 25 mg, and 50 mg.

Impax gets FDA OK for urinary retention drug (bizjournals.com via Yahoo! Finance)
Impax Laboratories Inc. has been granted U.S. Food and Drug Administration approval for generic versions of Urecholine, which is used for post-operative and post-partum urinary retention.

Boston Scientific Announces FDA Approval of NexStent(R) Carotid Artery Stenting System (PR Newswire via Yahoo! Finance)
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration has approved the NexStent Carotid Stent and Monorail Delivery System for use in patients with carotid artery disease who are at high risk for surgery.